Evaluation of the Ponto Bone Anchored Hearing System in a Pediatric Atresia Population
- Conditions
- Conductive Hearing LossHearing LossAtresia
- Interventions
- Device: Bone Achored Hearing surgery
- Registration Number
- NCT03723161
- Lead Sponsor
- Oticon Medical
- Brief Summary
The purpose of this study is to in a proactive manner collect high quality data from a pediatric patients who have undergone a bone anchored hearing solution, using the Ponto BHX implant, in clinical practice. This to further increase the knowledge of using the system.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
- Patients who have decided to undergo a Bone Anchored Hearing Surgery
- Diagnosed with atresia
- Signed informed consent
- Patients between 2,5 - 18 years of age
- Patients eligible for one stage surgery
- Not fluent in Swedish or English; subject and/or legal guardian
- Unwillingness to participate in follow up visits
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Treatment Bone Achored Hearing surgery Bone Anchored Hearing surgery using a BHX implant manufactured by Oticon Medical
- Primary Outcome Measures
Name Time Method Stability 12 months 12 months post surgery The development of implant stability during the first 12 months after implantation; as measured by difference in mean of (Implant Stability Quotient) ISQ low 12 months compared to surgery.
- Secondary Outcome Measures
Name Time Method Implant survival rate 24 months post surgery Implant survival rate in percent compared to litterature
Performance audibility PTA4 1 month post surgery The difference between abutment-aided and softband-aided sound field Pure Tone Average of thresholds at frequencies 500, 1000, 2000 and 4000 Hz (PTA 4) in preoperative condition and at fitting.
Functional assessment 12 months, 24 months Functional assessment as measured by change in Pediatric Evaluation of Aural/Oral Performance of Children (PEACH)
Skin conditions Holger 7-10 days,12 months, 24 months post surgery Skin assessment as assessed with maximum Holgers score per patient. Maximum score 4. 0= no adverse skin reaction, 4=maximum adverse skin reaction.
Stability 24 months 24 months post surgery Difference in mean of ISQ low at 24 months compared to surgery
Performance speech intelligibility 1 month post surgery Difference between abutment-aided and softband-aided speech intelligibility in SNR in preoperative condition and at fitting.
Skin conditions IPS evaluation 7-10 days,12 months, 24 months post surgery Skin condition as assessed by (Inflammation, Pain, Skin height/numbness (IPS) score. I scale randing from 0-4, Pain scale ranging from 0-2, Height scale ranging from 0-2. Total score 8, 0=no adverse skin reaction, 8=maximum adverse skin reaction
Performance audibility 1 month post surgery Difference between abutment-aided and softband-aided sound field Pure Tone thresholds at frequencies 500, 1000, 2000, 4000, 6000 and 8000 Hz) in preoperative condition and at fitting
Sustainability of audibility performance 1 month, 12 months, 24 months post surgey Difference between abutment aided sound field Pure Tone thresholds at frequencies 500, 1000, 2000, 4000, 6000 and 8000 Hz over time
Sustainability of audibility PTA4 performance 1 month, 12 months, 24 months post surgey Difference between abutment aided sound field PTA 4 over time
Sustainability of speech intelligibility performance 1 month, 12 months, 24 months post surgey Difference between abutment aided speech intelligibility over time
Trial Locations
- Locations (1)
Karolinska University Hospital
πΈπͺStockholm, Sweden